Converge Global, Inc. Share Price Other OTC
Equities
US21247M2098
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2020 | 3L 2.34Cr | Sales 2021 | 10.3L 8.59Cr | Capitalization | 85.47L 71Cr |
---|---|---|---|---|---|
Net income 2020 | -1.2Cr -100.1Cr | Net income 2021 | -1Cr -83Cr | EV / Sales 2020 | 50.5 x |
Net Debt 2020 | 11.97L 9.98Cr | Net Debt 2021 | 36.85L 31Cr | EV / Sales 2021 | 11.9 x |
P/E ratio 2020 |
-0.33
x | P/E ratio 2021 |
-0.62
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Jesus Quintero
CEO | Chief Executive Officer | 62 | 31/18/31 |
Glen Bonilla
SAM | Sales & Marketing | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jesus Quintero
CEO | Chief Executive Officer | 62 | 31/18/31 |
Marco Guerrero
BRD | Director/Board Member | 51 | 12/20/12 |
1st Jan change | Capi. | |
---|---|---|
-7.87% | 116.31Cr | |
-20.42% | 13Cr | |
0.00% | 7.48Cr | |
+2.57% | 5.92Cr | |
-4.79% | 5.12Cr |